Efficacy of Magnesium Sulfate versus nalbuphine On Hemodynamic Responses To Orotracheal Intubation I

Not Applicable

Recruiting

• Conditions: Circulatory System; smokers

• Registration Number: PACTR201703002107862
• Lead Sponsor: doaa rashwan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

The study population will include inpatients of the involved departments including
neurosurgery, general, urology, ENT, plastic and orthopedic surgery, both sex, selected
randomly according to American Society of Anesthesiologists(ASA) grade I , between
the ages of 18-50 years.

Exclusion Criteria

- History or suspected difficult airway.
- ASA physical status other than I.
- Patients undergoing cardiac and neurosurgical procedures.
- History of uncontrolled hypertension, myocardial ischemia, arrhythmias uncontrolled
diabetes mellitus and cerebrovascular stroke.
- Bronchial asthma.
- Renal disease, liver dysfunction, pregnancy.
- Patients on hypnotic or narcotic analgesic.
- History of alcohol or drug abuse.
- History of allergic reaction to opioids or any drug used in this study
- Patients in whom the duration of laryngoscopy exceeded 30 seconds.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mean arterial blood pressure

Secondary Outcome Measures

Name	Time	Method
heart rate